Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 451 participants.
Also called NCT03627884
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 451 participants
- Sponsor
- Coney Island Hospital, Brooklyn, NY
- Registry
-
NCT03627884
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT03627884. Randomized; no masking; primary purpose prevention. Start 2016-10-01 (actual); primary completion 2018-03-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
- Condition
- End Stage Renal Disease
- Condition
- Acute Renal Failure
- Condition
- Hemodialysis Catheter Infection
- Condition
- Hemodialysis Complication
- Condition
- Hemodialysis Access Failure
- Condition
- Hemodialysis Catheter-Associated Bacteremia
- Intervention (Drug)
- Sodium Bicarbonate Catheter Lock Solution
- Intervention (Drug)
- Normal Saline Catheter Lock Solution
- Lead sponsor
- Coney Island Hospital, Brooklyn, NY
Record details
- Record id
cardio:ct-nct03627884- Content hash
a8ed7b4de2d5d71b7fc824963a6e5f0616b13921f70bf58d7349caf0ab12ee93